Displaying items by tag: Division of Hematology and Oncology

The Nov. 10 workshop will provide information and resources for lung cancer patients.
UAB researcher reports that brentuximab vedotin may be effective therapy for older patients with Hodgkin Lymphoma who cannot tolerate standard therapy.
New UAB research demonstrates social factors that determine survival of younger patients with AML and present opportunities to improve outcomes.
Professor Ravi Bhatia, M.D., is the next holder of the Martha Ann and David L. May Endowed Chair in Cancer Research, and Professor Edward W. Hook III, M.D., was chosen to be the inaugural holder of the Cobbs Endowed Professorship in Infectious Diseases.
UAB presented an observational study at this week’s annual American Society of Clinical Oncology meeting in Chicago that indicates a more rapid decline in Medicare costs and patient resource utilization during implementation of a lay navigation program.
UAB presented an observational study at this week’s annual American Society of Clinical Oncology meeting in Chicago that indicates a more rapid decline in Medicare costs and patient resource utilization during implementation of a lay navigation program.
Page 4 of 5